ESSA Pharma Inc. - Kewajiban jangka dawa perusahaan EPIX

ESSA Pharma, Inc. - logo grafis emiten EPIX

ESSA Pharma Inc. (EPIX) is led by top oncologists who ensure transparency in R&D spending and the minimization of market risks. The firm's environmental policy is based on transitioning to green energy and the purification of laboratory emissions. Business protection is secured by patents for prostate cancer drugs, making the barrier to entry prohibitive for newcomers. Long-term debt stands at 0.00, which is clearly demonstrated by this price action chart.

EPIX (ESSA Pharma Inc.) riwayat Utang jangka dawa perusahaan saka 04.07.2022 nganti 25.10.2025
Produk seri ESSA Pharma Inc

Long-term debt aggregates total credit obligations and bonds with maturities exceeding one year, reflecting the financing strategy for capital expenditures and the risk of debt load. By analyzing the trend of the issuer's long-term liabilities, an investor can determine the volume of borrowed capital, which for the biotech company ESSA Pharma Inc. (EPIX) is directed toward costly clinical trials with minimal spending on environmental infrastructure.